磷酸化血管內(nèi)皮生長因子受體2抗體，VEGFR2（Tyr951）抗體

中文名稱：磷酸化血管內(nèi)皮生長因子受體2抗體，VEGFR2（Tyr951）抗體

英文名稱：Anti-phospho-VEGFR2（Tyr951）

貨號：BYK-2674R

克隆類型：polyclonal or monoclonal

抗體來源：Rabbit or Mouse
性狀：Lyophilized or Liquid
產(chǎn)品類型：一抗
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
標記物：可以提供抗體相對應(yīng)的 HRP   Biotin  Gold   RBITC   AP   FITC   Cy3 Cy5   Cy5.5   Cy7   PE   PE-Cy3   PE-CY5   PE-CY5.5   PE-CY7   APC   Alexa Fluor 350    Alexa Fluor 488    Alexa Fluor 555     Alexa Fluor 647 等標記物抗體，詳情請詢！

磷酸化血管內(nèi)皮生長因子受體2抗體，VEGFR2（Tyr951）抗體 詳細介紹：

VEGF receptor 2 is a member of a receptor tyrosine kinase family whose activation plays an essential role in a large number of biological processes such as embryonic development, wound healing, cell proliferation, migration and differentiation. Like other growth factor receptors, upon ligand binding VEGF receptor 2 dimerises and is autophosphorylated on multiple tyrosine residues. These sites can be involved in the regulation of kinase activity or serve as binding sites for SH2 and phosphotyrosine binding containing signalling proteins. Phosphorylation of Tyrosines 1054 and 1059 in the activation loop is required for activation of VEGF receptor 2 and its intrinsic tyrosine kinase activity. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

 本公司經(jīng)銷，并研發(fā)代理近萬種抗體產(chǎn)品，保證抗體產(chǎn)品質(zhì)量，質(zhì)量穩(wěn)定，實驗效果明顯，代理眾多抗體abcam，CST，R&D，santa等，貨期快，*，歡迎垂詢訂購！